Clinicogenomics for greater data insights
Better understand diseases and drug development opportunities with our genomics solution.
Unlock the potential of genomic data
The information within the human genome can help us diagnose rare diseases, identify individuals at risk of developing certain conditions and create effective treatment regimens. But today’s genomic data sets often come with limitations for researchers. They’re noisy, not representative, and lack information on the patient journey, limiting their value.
Optum Life Sciences combines the rich depth of genomic sequencing data with our world-class clinical and claims assets to offer researchers a new frontier in their search for life-changing treatments, vaccines and cures. Our research-ready, de-identified clinicogenomics data sets link genomic and other -omic data with the longitudinal health record, allowing for:
- Genotypic and phenotypic research across all stages of therapy development and use in the real world
- Comparison of clinical trial data to real-world data (RWD)
- Development of companion diagnostics
- Understanding the genetic testing landscape
With these real-world data, your teams can spend less time on unproductive research and development, and accelerate the time to market for innovative, targeted therapies.
How clinicogenomics data can catalyze research
Our white paper shares how this cutting-edge resource can fuel all stages of development.
Research-ready, on-demand data sets
Explore longitudinal phenotypic data that are linked to genomic data and designed to help you answer specific research questions. Download our fact sheets for these therapeutic areas.
Cardiology and metabolic conditions
Optum can focus a customized cohort on individuals who are diverse with unique combinations of comorbid profiles.
Oncology
Enable precision medicine, reveal the patient journey both before and after diagnosis, and help uncover new information about cancer types.
Autoimmune and inflammatory conditions
Explore the clinical and genomic pillars that reveal which patient populations should receive targeted treatments.
Are You Maximizing the ROI of Your Real-World Data?
Help your organization capitalize on these vital resources using lessons and tools compiled by the Optum life sciences real-world data team.
Challenges and opportunities with clinicogenomic data
Clinicogenomics: new, linked data is advancing research
Complementary solutions
Strengthen your value story with HEOR
Tap into our expertise in health economics and outcomes research (HEOR).
Engage payers with value-based contracts
Assess the fit, develop metrics and track care outcomes over time.
Generate evidence with real-world data
Derive evidence from the unmatched depth and scale of our data assets.